What is SCYX's P/E ratio?

SCYNEXIS INC (SCYX) currently trades at a P/E ratio of 24.17.

SCYNEXIS INC reports a Return on Equity (ROE) of -59.35%.

What is SCYX's dividend yield?

SCYNEXIS INC offers a dividend yield of 0.00%.

What is SCYX's Quality Score?

Our AI rates SCYX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy SCYX?

Our AI Timing Score for SCYX is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does SCYX belong to?

SCYNEXIS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange

SCYX (NASDAQ) Stock Analysis | SCYNEXIS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

SCYX AI Analysis Summary

Our AI summary for SCYX: SCYNEXIS INC (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 24.17, ROE of -59.35%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

SCYX

SCYNEXIS INC

USD 4.84

1.11 (29.76%) Day Change

Watchlist Portfolio Compare Chart

24.17

P/E

0.01

D/E

-59.4%

ROE

-31.6%

ROA

0.00%

Div Yield

SCYNEXIS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.84 Price 1.11 (29.76%) Day Change	NEWS SCORE: 83

SCYX, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

38%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	83
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.84
PBV / Sector	7.17 / 3.22
Earning Per Share	-0.40

PE / Sector	24.17 / 29.79
PEG or PE/Growth / Sector	N/A / 0.13
Average 1M Daily Value	1.06 M GREAT
Average 1W Daily Value	3.25 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-120.51 / 15.21
NPM Average (%) / Sector	-383.30 / -10.83
NPM Change Average (%) / Sector	-324.02 / 117.42
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-31.58 / 8.15
ROA Average (%) / Sector	-17.79 / 2.87
ROA Change Average (%) / Sector	-59.83 / 112.70
ROE (%) / Sector	-59.35 / -1.02
ROE Average (%) / Sector	-393.26 / 8.35
ROE Change Average (%) / Sector	-15.32 / 385.91
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.51
Dividend Average (%) / Sector	N/A / 3.06
Dividend Change Average (%) / Sector	N/A / 13.64

Registration Details

Analyze Date	2026-08-01 08:00:27
Symbol	SCYX
Name	SCYNEXIS INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	79.44 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	296.32 / 10,754.62

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548

Phone: 201 884 5485

Website: https://www.scynexis.com

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.